Comparative Pharmacology
Head-to-head clinical analysis: ISOLYTE R IN DEXTROSE 5 IN PLASTIC CONTAINER versus ISOLYTE S PH 7 4 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ISOLYTE R IN DEXTROSE 5 IN PLASTIC CONTAINER versus ISOLYTE S PH 7 4 IN PLASTIC CONTAINER.
ISOLYTE R IN DEXTROSE 5% IN PLASTIC CONTAINER vs ISOLYTE S PH 7.4 IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Electrolyte and fluid replacement; dextrose provides caloric support.
Isolyte S pH 7.4 is an isotonic crystalloid solution that expands intravascular volume and replaces extracellular fluid losses. It provides electrolytes (sodium, chloride, potassium, magnesium, acetate, gluconate) to maintain acid-base balance and osmotic pressure. Acetate and gluconate are metabolized to bicarbonate, providing alkalinizing effect.
Intravenous infusion; rate based on fluid and electrolyte requirements, typically 1-2 mL/kg/hour for maintenance in adults.
Intravenous infusion; dose depends on fluid and electrolyte needs, typically 500-3000 mL/24 hours for adults.
None Documented
None Documented
Not applicable; components are endogenous substances. Dextrose has a plasma half-life of approximately 1.5-2.5 hours in normal glucose metabolism; electrolytes have half-lives dependent on renal function (e.g., sodium half-life ~1-2 days).
Not applicable (components are endogenous substances; half-life reflects renal clearance and volume status, typically 2-4 hours for sodium and chloride in euvolemic patients).
Renal excretion of water and electrolytes; dextrose is metabolized to CO2 and water. >90% of water and electrolytes are excreted renally; dextrose is fully metabolized.
Renal: 100% (electrolytes and buffer components are excreted unchanged by the kidneys; no biliary or fecal elimination).
Category C
Category C
Intravenous Electrolyte Solution
Intravenous Electrolyte Solution